Meeder Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.71M Buy
65,603
+9,300
+17% +$716K 0.27% 77
2025
Q4
$4.47M Buy
56,303
+53,735
+2,092% +$4.24M 0.24% 74
2025
Q3
$194K Buy
2,568
+2,297
+848% +$157K 0.01% 216
2025
Q2
$18.7K Sell
271
-41,511
-99% -$2.72M ﹤0.01% 528
2025
Q1
$2.83M Buy
41,782
+41,430
+11,770% +$2.48M 0.19% 79
2024
Q4
$15.8K Sell
352
-9,933
-97% -$557K ﹤0.01% 594
2024
Q3
$647K Buy
10,285
+9,945
+2,925% +$580K 0.04% 161
2024
Q2
$20.1K Sell
340
-8,541
-96% -$534K ﹤0.01% 516
2024
Q1
$708K Sell
8,881
-88,442
-91% -$6.76M 0.04% 180
2023
Q4
$7.68M Buy
97,323
+86,005
+760% +$6.12M 0.6% 43
2023
Q3
$790K Sell
11,318
-31,240
-73% -$2.21M 0.06% 155
2023
Q2
$2.94M Sell
42,558
-3,192
-7% -$227K 0.21% 101
2023
Q1
$3.4M Buy
45,750
+10,923
+31% +$916K 0.27% 90
2022
Q4
$3.25M Sell
34,827
-17,979
-34% -$1.73M 0.28% 93
2022
Q3
$5.04M Buy
52,806
+8,089
+18% +$801K 0.29% 70
2022
Q2
$4.14M Sell
44,717
-8,920
-17% -$871K 0.24% 82
2022
Q1
$5.43M Buy
+53,637
New +$5.63M 0.26% 75
2021
Q4
Sell
-78,514
Closed -$6.66M 1446
2021
Q3
$6.66M Buy
78,514
+324
+0.4% +$27.1K 0.35% 73
2021
Q2
$6.52M Buy
78,190
+1,835
+2% +$150K 0.3% 75
2021
Q1
$5.75M Buy
76,355
+69,469
+1,009% +$5.06M 0.29% 76
2020
Q4
$470K Sell
6,886
-59,984
-90% -$3.9M 0.1% 159
2020
Q3
$3.9M Buy
66,870
+2,624
+4% +$163K 0.25% 86
2020
Q2
$4.17M Buy
64,246
+7,030
+12% +$443K 0.27% 81
2020
Q1
$3.4M Buy
57,216
+33,355
+140% +$2.23M 0.26% 85
2019
Q4
$1.77M Buy
23,861
+20,502
+610% +$1.44M 0.11% 169
2019
Q3
$212K Buy
3,359
+1,057
+46% +$62.6K 0.01% 593
2019
Q2
$125K Buy
2,302
+1,758
+323% +$94.7K 0.01% 694
2019
Q1
$30K Sell
544
-15,132
-97% -$934K ﹤0.01% 975
2018
Q4
$1.03M Buy
+15,676
New +$1.17M 0.09% 189
2018
Q2
Sell
-19,112
Closed -$1.19M 1584
2018
Q1
$1.19M Sell
19,112
-49,009
-72% -$3.52M 0.11% 178
2017
Q4
$4.94M Buy
68,121
+49,266
+261% +$3.58M 0.42% 57
2017
Q3
$1.53M Buy
18,855
+18,755
+18,755% +$1.48M 0.17% 155
2017
Q2
$8K Hold
100
﹤0.01% 1052
2017
Q1
$8K Hold
100
﹤0.01% 908
2016
Q4
$8K Hold
100
﹤0.01% 793
2016
Q3
$9K Sell
100
-36,192
-100% -$3.42M ﹤0.01% 713
2016
Q2
$3.48M Sell
36,292
-2,621
-7% -$261K 0.33% 58
2016
Q1
$4.04M Buy
38,913
+13,120
+51% +$1.28M 0.38% 54
2015
Q4
$2.52M Sell
25,793
-48,830
-65% -$4.78M 0.23% 122
2015
Q3
$7.2M Buy
74,623
+2,676
+4% +$281K 0.7% 23
2015
Q2
$7.54M Sell
71,947
-4,263
-6% -$436K 0.77% 19
2015
Q1
$7.87M Sell
76,210
-2,710
-3% -$274K 0.84% 18
2014
Q4
$7.6M Buy
78,920
+56,415
+251% +$4.97M 0.97% 18
2014
Q3
$1.79M Buy
+22,505
New +$1.77M 0.26% 105
2014
Q2
Sell
-101,750
Closed -$7.62M 342
2014
Q1
$7.62M Buy
+101,750
New +$7.19M 1.25% 21

Other funds holding CVS

Meeder Asset Management's CVS Position: Q1 2026 in Review

Meeder Asset Management increased its CVS Health (CVS) stake by 17% in Q1 2026, buying an estimated $716K and bringing the position to 65,603 shares worth $4.71M. The position accounts for 0.27% of the portfolio, ranked #77.

Meeder Asset Management first reported a position in CVS in Q1 2014 and has held it in 45 quarters since. The position peaked at $7.87M in Q1 2015. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Meeder Asset Management held 65,603 shares of CVS Health worth $4.71M as of Q1 2026.
  • Meeder Asset Management bought 9,300 CVS Health shares in Q1 2026, an estimated $716K.
  • CVS Health made up 0.27% of Meeder Asset Management's portfolio in Q1 2026, its #77 holding.
  • Meeder Asset Management first reported a position in CVS Health in Q1 2014 and has held it in 45 quarters since.
  • Meeder Asset Management's CVS Health position peaked at $7.87M in Q1 2015.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.